Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 254

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Resurgence in Diabetes-Related Complications

Gregg, Edward W., Hora, Israel, Benoit, Stephen R. · 2019 · JAMA

Abstract

The improved long-term outlook for adults after receiving a diagnosis of diabetes is one of the most important clinical and public health successes in recent decades. During the early 1990s, patients with diabetes had reductions in lifespan of 7 to 10 years and an increased risk oflower-extremityamputation(LEA)vsthosewithoutdiabetes (58 vs 3 cases/10 000 persons/year, respectively) and kidney failure (28 vs 2 cases/10 000 persons/year).1 Risk of cardiovascular events, which caused the most deaths, also was higher among persons with diabetes vs thosewithoutdiabetes(141vs38hospitalizationsforacute myocardial infarction [AMI] per 10 000 persons/year).1 But through multifaceted improvements in diabetes care, riskfactormanagement,self-managementeducationand support, and better integration of care, these risk differences were reduced by 28% to 68% across a range of complications between 1990 and 2010, with gains most notable for reductions in AMI, stroke, and death due to hyperglycemia.1,2 Although the excess morbidity risk remained too high and the reduction in cardiovascular disease mortality led to new types of complications and causesofdeath,3 acontinuedreductionintheoverallpublic health burden caused by diabetes seemed promising. However, in an unanticipated new challenge to these improvements, a resurgence of diabetes complications has appeared in national statistics and in the epidemiology literature. Between 2010 and 2015, an increase in diabetes-related LEAs occurred nationally, reversing more than one-third of the 20-year decline in only 5 years.4,5 For hyperglycemic crisis, annual emergency department visits almost doubled between 2009 and 2015 (from 16.2 to 29.4 per 1000), hospitalizations increased by 73% (from 15.3 to 26.6 per 1000), and deaths increased by 55% (from 15.7 to 24.2 per 1000).4 For endstage kidney disease, AMI, and stroke, the long-term improvements stalled after 2010. Updated national statistics indicate that the recent increase in complication rates is occurring in young and middle-aged adults (Figure), among whom the risk of hyperglycemic crisis, AMI, stroke, and LEAs each increased by more than 25% during only 5 years. Although the rebound in rates has been most apparent in young adults (aged 18-44 years), middle-aged adults (aged 45-64 years) have higher absolute rates and account for most of the increase. Among older adults, the long-term reductions in rates have reached a plateau (Figure). These changes may not be limited just to the population diagnosed with diabetes because improvements in AMI and stroke in the general population also have plateaued, and most counties in the United States have seen an increase in cardiovascular disease mortality among younger adults.6 Explaining these trends is difficult because of myriad potential factors inpreventivecare,patientcharacteristics, andsociety.Trackingincidenceofmajorchronicconditions relies on diagnoses and procedures that appear in administrative files, making systematic changes in coding a key consideration.Forexample,reimbursementincentivesthat affect upcoding of diabetes or changing diagnostic schemes could conceivably affect rates. However, there are no data to suggest that this has occurred, and the diversity of outcomes, consistency across data sources, and the use of 1 diagnostic classification system (International Classification of Diseases, Ninth Revision, Clinical Modification)pointstobroadercauses.Fourkeyplausiblesources of these changes warrant examination because understanding the modifiable etiology of this resurgence could be helpful in developing an effective response. First, there may be increasing heterogeneity or a changing profile for the population of new diabetes cases. The age divide in trends points toward the millennial generation (born roughly between 1980 and 2000) and their high obesity prevalence (approximately 35% with body mass index [calculated as weight in kilograms divided by heightinmeterssquared]>30),compoundedbyhigherlevels of smoking and poorer blood pressure and lipid level management seen among younger than older adults.2 These factors may be combining with chronic kidney disease to influence an earlier onset of macrovascular complications.Whethertrendsincomplicationratesvarybetween type1andtype2diabetesisnotclearduetodatalimitations in national surveys, but it is possible that a greater increase in type 2 diabetes than type 1 diabetes among nonwhites is gradually increasing the ratio of type 2 to type 1 diabetes and affecting the character of diabetes-related morbidity. For the middle-aged and older population in particular, the combinationofdecreasingmortalityamongthosewithdiabetesandrecentdecreasesindiabetesincidenceisincreasingtheaveragedurationofdiabetesinthepopulation.4 This shiftinthedistributionforthedurationofdiabetesmaynow be affecting the risk of complications. The effect of Medicaid expansion on detection of diabetes and the characteristics of the underlying population with diagnosed diabetes is also an open question. Second, there may be stagnation in preventive care, again most prominent among young adults. After encouraging reductions in hemoglobin A1c (HbA1c) levels among patients with diabetes through most of the 2000s, the proportion meeting individualized HbA1c targets declined from the 1990s to 2011-2014 by 6 percentage points overall and by 10 percentage points among young adults.7 The increase in suboptimal HbA1c levels occurred at a time when clinical organizations have encouraged better age and comorbidity personalization of treatment targets and prevention of hypoglycemia for older adults. Such efforts have been accompanied by a reduction in major hypoglycemic events,4 but also could be accompanied by an unintended relaxation of glycemic control targets for younger adults. The increases in LEAs could be driven more by clinical decision making about the management of VIEWPOINT

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2019.3471

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 254

Metadata

Authors
Gregg, E. W., Hora, I., & Benoit, S. R.
Venue
JAMA
Published
2019-05-21
Volume
321
Issue
19
Pages
1867
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2935837182
Cited by
254
References
9
FWCI
24.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resurgence in Diabetes-Related Complications. https://app.cochat.ai/papers/10.1001/jama.2019.3471
The paper
Gregg, E. W., Hora, I., & Benoit, S. R. (2019). Resurgence in Diabetes-Related Complications. JAMA. https://doi.org/10.1001/jama.2019.3471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.